SCHEMBL6244352

SCHEMBL6244352

C=C(c1ccc(Cl)cc1)c1ccc(NC(=O)OC(C)(C)C)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.43
TAS1R1 Q7RTX1 2/20 0.43
TAS1R2 Q8TE23 2/20 0.43
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 2/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39
CYP17A1 P05093 1/20 0.39
MAPT P10636 1/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731619 0.84 POLB (0.54) POLBKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL30587156 0.80 MAPT (0.46) TAS1R3TAS1R1TAS1R2KMT2ASMN1; SMN2
SCHEMBL628865 0.80 MAPT (0.46) TAS1R3TAS1R1TAS1R2KMT2ASMN1; SMN2
SCHEMBL6240779 0.80 ABCC9 (0.43) TAS1R3TAS1R1TAS1R2POLBKMT2A
SCHEMBL6242304 0.80 KMT2A (0.47) POLBKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL11959276 0.79 LCK (0.49) TAS1R3TAS1R1TAS1R2SMN1; SMN2NPC1
SCHEMBL6237795 0.79 RAB9A (0.42) TAS1R3TAS1R1TAS1R2POLBSMN1; SMN2
SCHEMBL6245740 0.78 ALDH1A1 (0.39) TAS1R3TAS1R1TAS1R2POLBKMT2A
SCHEMBL587939 0.78 ALDH1A1 (0.39) TAS1R3TAS1R1TAS1R2POLBKMT2A
SCHEMBL5154485 0.77 SMN1; SMN2 (0.43) POLBSMN1; SMN2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250822-A1 Substituted benzanilide compound and noxious organism controlling agent NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-11-10 US disclosed
EP-1538138-A1 SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250822-A1 Substituted benzanilide compound and noxious organism controlling agent GCN1, L3MBTL3, L3MBTL4 TAS1R3 1585/4885TAS1R1 1659/4885TAS1R2 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.